Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhizotomy | 2 | 2024 | 17 | 1.280 |
Why?
|
| Neurosurgical Procedures | 7 | 2024 | 303 | 1.280 |
Why?
|
| Craniotomy | 4 | 2019 | 106 | 0.920 |
Why?
|
| Infratentorial Neoplasms | 3 | 2020 | 46 | 0.920 |
Why?
|
| Muscle Spasticity | 1 | 2024 | 74 | 0.860 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 80 | 0.840 |
Why?
|
| Hypothalamic Diseases | 2 | 2022 | 37 | 0.840 |
Why?
|
| Hamartoma | 2 | 2022 | 52 | 0.830 |
Why?
|
| Brain Abscess | 2 | 2012 | 51 | 0.760 |
Why?
|
| Postoperative Complications | 5 | 2024 | 3078 | 0.750 |
Why?
|
| Laser Therapy | 2 | 2023 | 251 | 0.730 |
Why?
|
| Mechanical Thrombolysis | 1 | 2021 | 9 | 0.730 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 48 | 0.700 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 193 | 0.640 |
Why?
|
| Tumor Burden | 1 | 2020 | 236 | 0.640 |
Why?
|
| Nystagmus, Pathologic | 1 | 2018 | 22 | 0.600 |
Why?
|
| Dura Mater | 1 | 2018 | 24 | 0.600 |
Why?
|
| Cerebral Revascularization | 1 | 2018 | 21 | 0.590 |
Why?
|
| Mutism | 1 | 2018 | 31 | 0.590 |
Why?
|
| Strabismus | 1 | 2018 | 50 | 0.580 |
Why?
|
| Moyamoya Disease | 1 | 2018 | 38 | 0.580 |
Why?
|
| Vision Disorders | 1 | 2018 | 211 | 0.530 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 3622 | 0.510 |
Why?
|
| Brain Neoplasms | 7 | 2024 | 1324 | 0.510 |
Why?
|
| Craniosynostoses | 1 | 2018 | 133 | 0.510 |
Why?
|
| Registries | 1 | 2021 | 1453 | 0.450 |
Why?
|
| Visual Acuity | 1 | 2018 | 819 | 0.440 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 18 | 0.430 |
Why?
|
| Head Injuries, Closed | 1 | 2013 | 45 | 0.420 |
Why?
|
| Dermatitis, Contact | 1 | 2012 | 7 | 0.410 |
Why?
|
| Intracranial Hemorrhages | 1 | 2013 | 77 | 0.410 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 732 | 0.410 |
Why?
|
| Mitosporic Fungi | 1 | 2012 | 9 | 0.400 |
Why?
|
| Child | 20 | 2024 | 24740 | 0.400 |
Why?
|
| Spinal Cord Stimulation | 1 | 2012 | 10 | 0.400 |
Why?
|
| Posterior Horn Cells | 1 | 2012 | 5 | 0.400 |
Why?
|
| Implantable Neurostimulators | 1 | 2012 | 20 | 0.400 |
Why?
|
| Polytetrafluoroethylene | 1 | 2012 | 76 | 0.400 |
Why?
|
| Spinal Nerve Roots | 1 | 2012 | 26 | 0.400 |
Why?
|
| Lateral Ventricles | 1 | 2012 | 15 | 0.390 |
Why?
|
| Child, Preschool | 12 | 2024 | 14208 | 0.390 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 123 | 0.380 |
Why?
|
| Mycoses | 1 | 2012 | 117 | 0.360 |
Why?
|
| Arteriovenous Fistula | 2 | 2023 | 51 | 0.360 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12379 | 0.360 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2024 | 210 | 0.350 |
Why?
|
| Chronic Pain | 1 | 2012 | 124 | 0.340 |
Why?
|
| Retrospective Studies | 13 | 2024 | 16514 | 0.330 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2020 | 30 | 0.320 |
Why?
|
| Risk Assessment | 1 | 2018 | 3459 | 0.310 |
Why?
|
| Brain | 2 | 2023 | 3034 | 0.280 |
Why?
|
| Epilepsy | 3 | 2024 | 875 | 0.270 |
Why?
|
| Male | 18 | 2024 | 62009 | 0.270 |
Why?
|
| Adolescent | 10 | 2024 | 19531 | 0.270 |
Why?
|
| Humans | 30 | 2024 | 126285 | 0.260 |
Why?
|
| Infant | 9 | 2024 | 12667 | 0.260 |
Why?
|
| Female | 16 | 2024 | 67310 | 0.240 |
Why?
|
| Neurosurgery | 2 | 2018 | 75 | 0.230 |
Why?
|
| Seizures | 4 | 2023 | 872 | 0.220 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2024 | 55 | 0.220 |
Why?
|
| Supratentorial Neoplasms | 1 | 2023 | 37 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 214 | 0.210 |
Why?
|
| Hemispherectomy | 1 | 2023 | 26 | 0.200 |
Why?
|
| Pituitary Neoplasms | 2 | 2014 | 82 | 0.200 |
Why?
|
| Psychosurgery | 1 | 2023 | 27 | 0.200 |
Why?
|
| Cerebral Angiography | 2 | 2023 | 99 | 0.200 |
Why?
|
| Quality of Life | 3 | 2023 | 1954 | 0.190 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5199 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 219 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 655 | 0.180 |
Why?
|
| Epilepsies, Partial | 1 | 2020 | 92 | 0.160 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 53 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2019 | 53 | 0.160 |
Why?
|
| Esotropia | 1 | 2018 | 11 | 0.150 |
Why?
|
| Glioma | 1 | 2023 | 515 | 0.150 |
Why?
|
| Thrombosis | 1 | 2023 | 524 | 0.150 |
Why?
|
| Young Adult | 4 | 2020 | 9165 | 0.150 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 49 | 0.150 |
Why?
|
| Ependymoma | 1 | 2020 | 164 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 135 | 0.140 |
Why?
|
| Neoplasms | 1 | 2012 | 2805 | 0.140 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 127 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 165 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 198 | 0.140 |
Why?
|
| Recurrence | 1 | 2021 | 1397 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 589 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2106 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 577 | 0.130 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 867 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 477 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 261 | 0.130 |
Why?
|
| Cardiovascular System | 1 | 2017 | 109 | 0.120 |
Why?
|
| Middle Aged | 7 | 2017 | 27028 | 0.120 |
Why?
|
| Cerebellum | 1 | 2018 | 443 | 0.120 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 35 | 0.110 |
Why?
|
| Neuroendoscopy | 1 | 2013 | 25 | 0.110 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 82 | 0.110 |
Why?
|
| Radiotherapy | 1 | 2014 | 140 | 0.100 |
Why?
|
| Back | 1 | 2012 | 11 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3715 | 0.100 |
Why?
|
| Length of Stay | 2 | 2020 | 1325 | 0.100 |
Why?
|
| Parents | 1 | 2019 | 1028 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2018 | 653 | 0.100 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 64 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 133 | 0.100 |
Why?
|
| Risk Factors | 4 | 2019 | 10372 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 248 | 0.100 |
Why?
|
| Exanthema | 1 | 2012 | 71 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2013 | 198 | 0.090 |
Why?
|
| Osteosarcoma | 1 | 2014 | 255 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1361 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 2012 | 294 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2012 | 304 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 890 | 0.080 |
Why?
|
| Pediatrics | 1 | 2018 | 1161 | 0.080 |
Why?
|
| United States | 2 | 2018 | 10988 | 0.060 |
Why?
|
| Hydrocephalus | 2 | 2018 | 244 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 1972 | 0.060 |
Why?
|
| Pinealoma | 1 | 2024 | 22 | 0.060 |
Why?
|
| Pons | 1 | 2023 | 33 | 0.050 |
Why?
|
| Adult | 4 | 2019 | 29791 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 295 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2405 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 3166 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2024 | 445 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1257 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 6175 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2023 | 876 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 123 | 0.040 |
Why?
|
| Scoliosis | 1 | 2018 | 135 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 477 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 111 | 0.030 |
Why?
|
| India | 1 | 2017 | 213 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 308 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 422 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8302 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1436 | 0.030 |
Why?
|
| Inpatients | 1 | 2020 | 505 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 477 | 0.030 |
Why?
|
| Spinal Dysraphism | 1 | 2018 | 270 | 0.030 |
Why?
|
| Sphenoid Sinus | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 11 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 771 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1193 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2013 | 45 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 363 | 0.030 |
Why?
|
| Nose | 1 | 2013 | 95 | 0.030 |
Why?
|
| Hyponatremia | 1 | 2013 | 73 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2013 | 397 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2013 | 473 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 5956 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 635 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1274 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 19960 | 0.010 |
Why?
|